{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:30:29Z","timestamp":1793230229289,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtct.2026.01.026","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:50:02Z","timestamp":1768895402000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8355-433X","authenticated-orcid":false,"given":"Sergio","family":"Rodriguez-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-3682","authenticated-orcid":false,"given":"Maria Queralt","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihar","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-4626","authenticated-orcid":false,"given":"Eshrak","family":"Al-Shaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Novitzky-Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios V.","family":"Michelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-6644","authenticated-orcid":false,"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Dong Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-5699","authenticated-orcid":false,"given":"Rajat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4171-4678","authenticated-orcid":false,"given":"Tommy Alfaro","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jtct.2026.01.026_bib0001","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ajh.27625","article-title":"Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2026.01.026_bib0002","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41409-025-02701-3","article-title":"Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations","volume":"60","author":"Greco","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.01.026_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659595","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia: who, when, and how?","volume":"12","author":"Loke","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.026_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/bjh.16355","article-title":"The role of allogeneic stem cell transplantation in the management of acute myeloid Leukaemia: a triumph of hope and experience","volume":"188","author":"Loke","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.026_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: definition and natural history","volume":"27","author":"Xue","year":"2011","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.026_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/bmt.2017.192","article-title":"Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?","volume":"53","author":"Hegde","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"22","key":"10.1016\/j.jtct.2026.01.026_bib0007","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.026_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41409-020-0979-1","article-title":"Pilot prospective study of frailty and functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation","volume":"56","author":"Salas","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.026_bib0009","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41409-022-01892-3","article-title":"Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults","volume":"58","author":"Salas","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.026_bib0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"Can Med Assoc J"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.026_bib0011","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s41409-023-02088-z","article-title":"HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation","volume":"58","author":"Salas","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.026_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.026_bib0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.026_bib0014","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.026_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.026_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103509","article-title":"Relationship of self-rated health with fatal and non-fatal outcomes in cardiovascular disease: a systematic review and meta-analysis","volume":"9","author":"Mavaddat","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.026_bib0017","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12185-016-1941-2","article-title":"Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Yamamoto","year":"2016","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.026_bib0018","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/bmt.2017.51","article-title":"Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation","volume":"52","author":"Chee","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.026_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27089","article-title":"Acute myelogenous leukemia in adolescents and young adults","volume":"65","author":"Creutzig","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.026_bib0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.jtct.2026.01.026_bib0021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4235\/agmr.21.0080","article-title":"Frailty and biological age","volume":"25","author":"Ji","year":"2021","journal-title":"Ann Geriatr Med Res"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.026_bib0022","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.026_bib0023","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.01.026_bib0024","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.htct.2023.07.008","article-title":"Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era","volume":"46","author":"Salas","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"13","key":"10.1016\/j.jtct.2026.01.026_bib0025","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/bloodadvances.2025015793","article-title":"Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704","volume":"9","author":"Sorror","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.01.026_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1512154","article-title":"Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care","volume":"15","author":"Salas","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.026_bib0027","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41409-025-02571-9","article-title":"Frailty assessment and outpatient pre-habilitation for adults undergoing allogeneic hematopoietic cell transplantation","volume":"60","author":"Salas","year":"2025","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:08:44Z","timestamp":1776856124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"alternative-id":["S2666636726000606"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.026","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty as a Prognostic Factor in Younger Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}